title: Magnesium sulfate therapy in patients with acute neuronal damage: The problem of intravenous administration.
authors.forename: Kenji
authors.initials: K
authors.lastname: Dohi
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Ohtaki
authors.forename: Seiji
authors.initials: S
authors.lastname: Shioda
authors.forename: Tohru
authors.initials: T
authors.lastname: Aruga
mesh_terms: D001682:Biological Availability; D001921:Brain / Q000378:metabolism*; D001930:Brain Injuries / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D008274:Magnesium / Q000134:cerebrospinal fluid*; D008278:Magnesium Sulfate / Q000008:administration & dosage / Q000493:pharmacokinetics*; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D018696:Neuroprotective Agents; D008278:Magnesium Sulfate; D008274:Magnesium